You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

132 Results
Symptom Management
Document
Aug 2017
Guidelines and Advice
Status: Current
ID: GL-C50-09
Jun 2019
Drug
Other Name(s): Revlimid®
Quick Link(s): Drug Monograph, Patient Info Sheet
Mar 2024
Drug
Other Name(s): Lederle Leucovorin® (multiple brands available)
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2019
Drug
Other Name(s): CeeNU®
Quick Link(s): Drug Monograph, Patient Info Sheet
Aug 2024
Drug
Other Name(s): Lenvima®
Quick Link(s): Drug Monograph, Patient Info Sheet
Sep 2023
Drug
Other Name(s): Somatuline® Autogel®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2024
Drug
Other Name(s): Onivyde® (Baxalta Canada)
Quick Link(s): Drug Monograph, Patient Info Sheet
Sep 2017
Regimen
Cancer Type:
Hematologic, 
Myelodysplastic Syndrome (MDS)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB Limited Use
    lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
lenalidomide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2022

Pages